High levels of RIP1/3 signaling stabilize SOCS1, and SOCS1 antagonizes IFNγ signaling, effectively protecting AML cells from the differentiation-inducing effects of IFNγ (78). This evidence concerns the gene IFNG and acute myeloid leukemia.